Nebenwirkungen · Enbrel
Enbrel 10 mg powder and solvent for solution for injection for paediatric use · Abschnitt 4.8 · PDF-Seite 135
HOS-090486 · Präparat HOS-084041
Elevated liver enzymes In the double-blind periods of controlled clinical trials of etanercept across all indications, the frequency (incidence proportion) of adverse events of elevated liver enzymes in patients receiving etanercept without concomitant methotrexate was 0.54% (frequency uncommon). In the double-blind periods of controlled clinical trials that allowed concomitant treatment with etanercept and methotrexate, the frequency (incidence proportion) of adverse events of elevated liver enzymes was 4.18% (frequency common).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-08-13T14:40:00Z · SHA-256 2c6500390fb2c4d6c023708f4ad5e87e0680d81ce838cfcbebc32899e1a4b8e3 · Passage 89de4db467a7e4fb35688928df56933201b85a16ad601fae1dbaef25356d3862 · Zeichen 22272–22807 im Abschnitt